While everyone chases shiny mental health apps for consumers, NeuroFlow built the invisible infrastructure that actually moves the needle for payors and health systems. This is the boring, necessary work of scaling behavioral health.

"NeuroFlow doesn't sell therapy apps—it sells risk stratification algorithms that make behavioral health measurable for the entire healthcare system."

The leadership team is telling: CEO Christopher Molaro (ex-PharmD), Chief Revenue Officer Neal Smart, and Chief Marketing Officer Robert Capobianco all come from healthcare/pharma backgrounds. This isn't a team of pure tech founders—they understand the complex procurement cycles and regulatory maze of healthcare systems. Their CMO is also Payer Market President, signaling deep focus on the insurance side where the real money flows.

• Targeting the B2B2C model: selling to payors/health systems who manage patient populations
• Risk stratification at scale is their core IP—identifying high-risk patients before they escalate
• 19 tech stack components suggest a mature, integrated platform (jQuery, Tailwind, Bootstrap, Ant Design)
• Zero public traffic data indicates they're not chasing consumer eyeballs—they're enterprise-focused